Comparison of Cytokine Responses (IL-21, IL-12, IL-13) in Chlamydia pneumoniae-Stimulated PBMC in Asthma and Non-Asthma
- PMID: 39293844
Comparison of Cytokine Responses (IL-21, IL-12, IL-13) in Chlamydia pneumoniae-Stimulated PBMC in Asthma and Non-Asthma
Abstract
Objective: Chlamydia pneumoniae (C. pneumoniae) is a gram-negative intracellular bacterium that causes respiratory infections in humans. C. pneumoniae is responsible for cell activation and production of cytokines that may contribute to inflammatory responses in asthma. Cell-mediated immune responses are important for protective immunity; however, these responses may be impaired in asthma. In this study, we examined cytokine responses (IL-21, IL-12, IL-13) responsible for T helper (Th)1 versus Th2 responses in C. pneumoniae-stimulated PBMC from subjects with or without asthma. These cytokines could be potential biomarkers in the evaluation of past C. pneumoniae infection.
Methods: Peripheral blood mononuclear cells (PBMC) (1×106/mL) from stable adult asthmatic (N=6) and non-asthmatic subjects (N=6) were infected +/- C. pneumoniae TW-183 at a multiplicity of infection (MOI)=0.1, using dose responses (1:10, 1:100), and cultured 48 hrs. Cytokine responses (Interleukin (IL)-21, IL-12, IL-13) were measured in supernatants (ELISA).
Results: Cytokine responses (mean differences: unstimulated-stimulated cells) were significant for IL-12 (1:10, 1:100) (P=0.0005, 0.0005) but not for IL-21 or IL-13 (Wilcoxon signed-rank test). Cytokine levels were higher in asthmatic subjects for IL-13 (mean differences: non-asthma-asthma) (unstimulated, 1:10, 1:100) (-210±167, -140±113, -89±59, respectively) (P=0.05, 0.05, 0.05, respectively) compared with non-asthma. However, IL-21 and IL-12 responses were similar in both groups. When subjects were stratified according to C. pneumoniae IgG antibody status, no significant differences in cytokine responses were observed.
Conclusion: Differential cytokine patterns in subjects with or without asthma may suggest a mechanism for the development of persistent infection with C. pneumoniae.
Keywords: Chlamydia pneumoniae; cytokines.
© 2024 by the Association of Clinical Scientists, Inc.
Similar articles
-
IL-10 Cytokine Responses in Chlamydia pneumoniae-Stimulated Human Peripheral Blood Mononuclear Cells.Ann Clin Lab Sci. 2025 Jan;55(1):79-83. Ann Clin Lab Sci. 2025. PMID: 40089282
-
Chlamydia pneumoniae enhances the Th2 profile of stimulated peripheral blood mononuclear cells from asthmatic patients.Hum Immunol. 2016 May;77(5):382-8. doi: 10.1016/j.humimm.2016.02.010. Epub 2016 Feb 26. Hum Immunol. 2016. PMID: 26924667
-
Chlamydia pneumoniae induces interleukin-12 responses in peripheral blood mononuclear cells in asthma and the role of toll like receptor 2 versus 4: a pilot study.Ir J Med Sci. 2017 May;186(2):511-517. doi: 10.1007/s11845-016-1549-9. Epub 2016 Dec 29. Ir J Med Sci. 2017. PMID: 28035483
-
Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.J Infect Chemother. 2018 Jun;24(6):470-475. doi: 10.1016/j.jiac.2018.02.004. Epub 2018 Mar 31. J Infect Chemother. 2018. PMID: 29615379
-
Azithromycin decreases Chlamydia pneumoniae-mediated Interleukin-4 responses but not Immunoglobulin E responses.PLoS One. 2020 Jun 8;15(6):e0234413. doi: 10.1371/journal.pone.0234413. eCollection 2020. PLoS One. 2020. PMID: 32511255 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous